Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.
Karenfort
Michael
M
Kieseier
Bernd C
BC
Tibussek
Daniel
D
Assmann
Birgit
B
Schaper
Joerg
J
Mayatepek
Ertan
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab